HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 1 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $536,000 | +12.4% | 1,622,945 | +144.9% | 0.00% | – |
| Q2 2020 | $477,000 | +1544.8% | 662,705 | +1423.5% | 0.00% | – |
| Q3 2019 | $29,000 | -61.3% | 43,500 | +299.1% | 0.00% | – |
| Q1 2017 | $75,000 | -42.3% | 10,900 | -81.3% | 0.00% | – |
| Q4 2016 | $130,000 | +30.0% | 58,200 | +32.3% | 0.00% | – |
| Q3 2016 | $100,000 | +31.6% | 43,994 | +57.0% | 0.00% | – |
| Q2 2016 | $76,000 | – | 28,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 466 | $2,000 | 0.00% |